Stock Analiz

Icu Medical Inc (ICUI) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Icu Medical’s revenue went from $379M in fiscal 2016 to $2.2B in fiscal 2025, growth of about 21.8% a year.

Net income in fiscal 2025 was $732000, a net margin of 0.0%; the best year in this period was 2021 with $103M.

Over the twelve months to September 30, 2026, revenue was $2.2B and net income $60M.

Free cash flow was $92M in fiscal 2025 and positive in 9 of the 10 years shown.

The diluted share count rose 44% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $379M162017: $1.3B172018: $1.4B182019: $1.3B192020: $1.3B202021: $1.3B212022: $2.3B222023: $2.3B232024: $2.4B242025: $2.2B25$2.2B
Net income
2016: $63M162017: $69M172018: $29M182019: $101M192020: $87M202021: $103M212022: -$74M222023: -$30M232024: -$118M242025: $73200025$732000
Free cash flow
2016: $67M162017: $80M172018: $67M182019: $5M192020: $131M202021: $199M212022: -$152M222023: $82M232024: $125M242025: $92M25$92M
EPS (diluted)
2016: $3.66162017: $3.29172018: $1.33182019: $4.69192020: $4.02202021: $4.74212022: $-3.11222023: $-1.23232024: $-4.83242025: $0.0325$0.03

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$2.2B$2.2B$2.4B$2.3B$2.3B$1.3B$1.3B$1.3B$1.4B$1.3B$379M
Gross profit$879M$822M$825M$740M$698M$491M$461M$472M$570M$426M$201M
Operating income$111M$43M$43M$23M-$43M$123M$98M$107M$30M-$13M$83M
Net income$60M$732000-$118M-$30M-$74M$103M$87M$101M$29M$69M$63M
EPS (diluted)$2.40$0.03$-4.83$-1.23$-3.11$4.74$4.02$4.69$1.33$3.29$3.66
R&D$87M$87M$89M$85M$93M$47M$43M$49M$53M$51M$13M
Revenue growth—−6.3%+5.4%−0.9%+73.2%+3.6%+0.4%−9.6%+8.3%+240.7%+11.0%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$279M$180M$204M$166M-$62M$268M$223M$102M$160M$154M$90M
Capital spending-$71M-$88M-$79M-$84M-$90M-$69M-$92M-$97M-$93M-$74M-$23M
Free cash flow$209M$92M$125M$82M-$152M$199M$131M$5M$67M$80M$67M
Dividends paid—$0$0$0$0$0$0$0$0$0$0
Buybacks—$9M$12M$9M$11M$8M$13M$19M$6M$4M$17M
Stock-based pay$52M$56M$47M$41M$36M$27M$24M$22M$24M$19M$15M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$308M$309M$255M$213M$567M$411M$269M$345M$290M$445M
Debt—$1.3B$1.6B$1.7B$1.7B$43M$50M$111M$75M$75M—
Equity—$2.1B$2.0B$2.1B$2.1B$1.6B$1.5B$1.4B$1.3B$1.2B$660M
Total assets—$4.1B$4.2B$4.4B$4.5B$1.9B$1.8B$1.7B$1.6B$1.5B$705M
Shares (diluted)25M25M24M24M24M22M22M22M22M21M17M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin40.3%36.8%34.6%32.8%30.6%37.3%36.3%37.3%40.7%33.0%53.1%
Operating margin5.1%1.9%1.8%1.0%-1.9%9.4%7.7%8.5%2.1%-1.0%21.9%
Net margin2.8%0.0%-4.9%-1.3%-3.3%7.8%6.8%8.0%2.1%5.3%16.6%
FCF margin9.6%4.1%5.2%3.6%-6.7%15.1%10.3%0.4%4.8%6.2%17.5%
ROIC—1.0%0.9%0.5%-0.9%5.9%5.6%6.3%1.8%-0.8%9.3%
ROE—0.0%-6.0%-1.4%-3.5%6.4%5.8%7.3%2.3%5.7%9.6%

Frequently asked questions

What is Icu Medical’s annual revenue?

$2.2B in fiscal 2025 and $2.2B over the twelve months to September 30, 2026.

How much profit does Icu Medical make?

Net income was $732000 in fiscal 2025 (net margin 0.0%).

Is Icu Medical’s revenue growing?

No: revenue fell 6.3% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.